Elevated exercise ventilation in mild COPD is not linked to enhanced central chemosensitivity.


Journal

Respiratory physiology & neurobiology
ISSN: 1878-1519
Titre abrégé: Respir Physiol Neurobiol
Pays: Netherlands
ID NLM: 101140022

Informations de publication

Date de publication:
02 2021
Historique:
received: 03 07 2020
revised: 27 10 2020
accepted: 01 11 2020
pubmed: 9 11 2020
medline: 25 11 2021
entrez: 8 11 2020
Statut: ppublish

Résumé

The purpose of this study was to determine if altered central chemoreceptor characteristics contributed to the elevated ventilation relative to carbon dioxide production (V̇ Twenty-nine mild COPD and 19 healthy age-matched control participants undertook lung function testing followed by symptom-limited incremental cardiopulmonary exercise testing . On a separate day, basal (non-chemoreflex) ventilation (V̇ At standardized exercise intensities, absolute V̇ These data have established that excessive exercise ventilation in mild COPD is not explained by altered central chemosensitivity.

Sections du résumé

BACKGROUND
The purpose of this study was to determine if altered central chemoreceptor characteristics contributed to the elevated ventilation relative to carbon dioxide production (V̇
METHODS
Twenty-nine mild COPD and 19 healthy age-matched control participants undertook lung function testing followed by symptom-limited incremental cardiopulmonary exercise testing . On a separate day, basal (non-chemoreflex) ventilation (V̇
RESULTS
At standardized exercise intensities, absolute V̇
CONCLUSION
These data have established that excessive exercise ventilation in mild COPD is not explained by altered central chemosensitivity.

Identifiants

pubmed: 33161118
pii: S1569-9048(20)30230-5
doi: 10.1016/j.resp.2020.103571
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

103571

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Auteurs

Devin B Phillips (DB)

Respiratory Investigation Unit, Department of Medicine, Queen's University and Kingston Health Sciences Centre Kingston General Hospital Campus, Kingston, Ontario, Canada.

Nicolle J Domnik (NJ)

Respiratory Investigation Unit, Department of Medicine, Queen's University and Kingston Health Sciences Centre Kingston General Hospital Campus, Kingston, Ontario, Canada.

Amany F Elbehairy (AF)

Respiratory Investigation Unit, Department of Medicine, Queen's University and Kingston Health Sciences Centre Kingston General Hospital Campus, Kingston, Ontario, Canada; Department of Chest Diseases, Faculty of Medicine, Alexandria University, Alexandria, Egypt.

Megan E Preston (ME)

Respiratory Investigation Unit, Department of Medicine, Queen's University and Kingston Health Sciences Centre Kingston General Hospital Campus, Kingston, Ontario, Canada.

Kathryn M Milne (KM)

Respiratory Investigation Unit, Department of Medicine, Queen's University and Kingston Health Sciences Centre Kingston General Hospital Campus, Kingston, Ontario, Canada; Department of Medicine Clinician Investigator Program, University of British Columbia, Vancouver, British Columbia, Canada.

Matthew D James (MD)

Respiratory Investigation Unit, Department of Medicine, Queen's University and Kingston Health Sciences Centre Kingston General Hospital Campus, Kingston, Ontario, Canada.

Sandra G Vincent (SG)

Respiratory Investigation Unit, Department of Medicine, Queen's University and Kingston Health Sciences Centre Kingston General Hospital Campus, Kingston, Ontario, Canada.

Megha Ibrahim-Masthan (M)

Respiratory Investigation Unit, Department of Medicine, Queen's University and Kingston Health Sciences Centre Kingston General Hospital Campus, Kingston, Ontario, Canada.

J Alberto Neder (JA)

Respiratory Investigation Unit, Department of Medicine, Queen's University and Kingston Health Sciences Centre Kingston General Hospital Campus, Kingston, Ontario, Canada.

Denis E O'Donnell (DE)

Respiratory Investigation Unit, Department of Medicine, Queen's University and Kingston Health Sciences Centre Kingston General Hospital Campus, Kingston, Ontario, Canada. Electronic address: odonnell@queensu.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH